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Characterization of specific host cell receptors for enveloped viruses is a difficult problem
because many enveloped viruses bind to a variety ofsubstrates which are not obviously related
to tissue tropisms in the intact host. Viruses with a limited cellular tropism in infected animals
present useful models for studying the mechanisms by which virus attachment regulates the
disease process. Rabies virus is a rhabdovirus which exhibits a marked neuronotropism in in-
fected animals. Limited data suggest that spread occurs by transsynaptic transfer ofvirus. The
results ofrecent experiments at Yale suggest that viral antigen is localized very soon after injec-
tion at neuromuscular junctions, the motor nerveendings on muscle tissue. On cultured muscle
cells, similar co-localization with the acetylcholine receptor is seen both before and after virus
multiplication. Pretreatment of these cells with some ligands of the acetylcholine receptor
results in reduced viral infection. These findings suggest that a neurotransmitter receptor or a
closely associated molecule may serve as a specific host cell receptor for rabies virus and thus
may be responsible for the tissue tropism exhibited by this virus. In addition to clarifying
aspects of rabies virus pathogenesis, these studies have broad implications regarding the
mechanism by which other viruses or viral immunizations might mediate autoimmune diseases
such as myasthenia gravis.
INTRODUCTION
Rabies virus belongs to the rhabdovirus family, Lyssavirus genus, which are
enveloped, negative-stranded RNA viruses with a distinctive morphology resembling
a bullet (for review, see [1,2]). The disease is characterized by extensive involvement
of the central nervous system and almost always ends in a fatal outcome after the
onset of clinical signs or symptoms. The pathogenesis of rabies virus infection with
its restricted spread to defined cell types, especially neurons, argues for the existence
ofhighly specific host cell receptors. In this briefreview, we summarize current liter-
ature regarding host cell receptors for enveloped viruses and the role of these recep-
tors in the pathogenesis of virus infections. In addition, we discuss the role of at-
tachment ingoverning the pathogenesis ofrabies virus infection and propose sites of
rabies virus entry into the peripheral nervous system. An hypothesis defining the
identity of a highly specific host cell receptor is reviewed. The relevance of ex-
perimental findings with rabies virus to the study of other neurologic disorders is
presented.
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All rights of reproduction in any form reserved.INTERACTION OF VIRUSES WITH CELL SURFACE RECEPTORS
The first step in the interaction ofviruses and cells is the attachment of the virus to
the cell surface (for review, see [3]). In the virus-host cell infectious cycle, attach-
ment is followed by entry of the virus into the cell, uncoating of the nucleic acid,
transcription and translation directing synthesis of viral proteins, replication of viral
nucleic acid, assembly of virus, and release of virus particles from the cell. Attach-
ment of the virus to the cell surface is mediated by specific components on the sur-
face of the virus which interact with complementary molecules on the cell surface.
There is considerable evidence that the specific attachment components of
enveloped viruses are glycoproteins. Enveloped viruses, including rabies virus, are
usually covered with glycosylated proteins, forming spikes extending from a lipid
bilayer membrane. Removal of the virus spike glycoprotein enzymatically or
genetically renders some negative-stranded viruses noninfectious [4,5]. For several
enveloped viruses, the glycoproteins involved in attachment of the virus to some cell
surfaces have been identified [6,7,8].
In general, less is known about the molecular structure of the host cell receptors
for viruses (reviewed in [9,10]). The plasma membrane of the cell is a lipid bilayer
composed of phospholipids, cholesterol, glycolipids, and gangliosides. Embedded
within and spanning the lipid bilayer are integral membrane glycoproteins with the
terminal glycosylated segment of the polypeptide chain facing the outside. In addi-
tion, more weakly associated with the membrane are peripheral or extrinsic mem-
brane proteins. Membrane proteins accessible to the exterior include regulatory
molecules, enzymes, ion channels, recognition sites for other cells, and receptors for
hormones, neurotransmitters, and immunoglobulins [9]. It is likely that some of
these normal surface components serving useful cellular functions have been
usurped and used as receptors by viruses [2]. The specificity, number, and distribu-
tion of these cellular receptors has been hypothesized to be responsible for the
species specificity and tissue tropisms of viruses [11,12]. Thus, identification of the
cellular receptors for viruses could contribute considerably to understanding the ini-
tial stages ofviral infection and the relationship ofthis step in viral replication to the
pathogenesis of viral diseases.
Although the precise functional identity of the molecules on cell surfaces serving
as receptors for most viruses is unknown, the receptors are often sensitive to pro-
teolytic enzymes, demonstrating that they are proteins or glycoproteins [13,14,15].
In some cases, the host cell receptor is essential for the constitutive functioning of
the cell, since the receptors cannot be cleaved by proteolytic enzymes without killing
the cell [15]. Neuraminic acid or its derivatives (sialic acids) have been identified as
attachment determinants for many myxoviruses (influenza) and paramyxoviruses
(parainfluenza, mumps) [6,8,16]. The binding site for Epstein-Barr virus on lym-
phoid cells is closely associated with but not identical to complement (C3d) receptors
[17]. Finally, Semliki Forest virus spike proteins may bind to human HLA-A and
HLA-B and murine H2K and H2D histocompatibility antigens [18], although it is
uncertain that these antigens are specific receptors [19]. Thus, any molecule
associated with the cell surface represents a potential virus receptor if it possesses the
ability to interact with components on the surface of the virus.
However, enveloped viruses may bind to many cell types and inanimate surfaces,
such as glass or nitrocellulose, which are not obviously related to tissue tropism. A
molecule can be considered a specific receptor if its interaction with the virus is
followed by internalization and infection [3,10]. Difficulties in defining specificity
316
LENTZ ET AL.RABIES VIRUS RECEPTOR
of receptors have been discussed elsewhere [3,20]. The concept of specific receptors
is helpful but not entirely accurate, since binding to red blood cells, for example, is
an important pathogenic mechanism contributing to spread of some viruses
although the virus may not replicate in these cells. In addition, binding of virus to
cell receptors is only the first in a series of steps determining specific cell vulnerabil-
ity and does not always guarantee successful viral production [21]. For example,
many molecules after binding to their specific receptors on the cell surface are inter-
nalized within coated vesicles, a process known as receptor-mediated or absorptive
endocytosis. It has been demonstrated that Semliki Forest virus, an enveloped virus
of the Togavirus family, binds to the cell surface and enters by absorptive en-
docytosis [22]. Defects in internalization after binding can lead to a failure in
replication.
Specificity of attachment may reside in the particular amino acid sequence of a
polypeptide or in a carbohydrate side chain occupying only a portion of a large
molecule. In the case of rabies virus, a single amino acid substitution replacing
arginine at position 333 of the glycoprotein molecule renders the virus non-
pathogenic [23]. Specific amino acid sequences on the host cell may similarly govern
attachment. These determinants may be shared by different molecules on a variety
of cell types and their distribution may establish the host cell specificity for a par-
ticular virus.
SITES OF ATTACHMENT AND SPREAD OF RABIES VIRUS
Rabies virus is usually transmitted from animal to animal by inoculation as a
result of bites (see [24] for a review of the pathogenesis of rabies). The incubation
period for rabies is often variable and during this period viral replication in striated
muscle has been observed [25,26,27]. It has been suggested that initial infection of
muscle might be crucial in amplifying the inoculum virus which subsequently enters
the peripheral nervous system. Forty-eight hours after intramuscular inoculation
of rabies virus into infant rodents, viral antigen has been localized by im-
munofluorescence in neuromuscular and neurotendinal spindles [24,28]. These sen-
sory stretch receptor organs were postulated to represent the probable deep sites of
viral entry into the nervous system, although virus particles could be observed at
motor nerve terminals (neuromuscular junctions) by electron microscopy [29].
Other evidence indicates that rabies enters the nervous system through the motor
nerve terminal [27]. Rabies virus antigen could be detected on muscle cells ofmice at
sites similar in form and distribution to cholinesterase-positive sites (neuromuscular
junctions) one hour after inoculation. A similar distribution of labeled virus could
be detected by autoradiography six hours after infection. These findings dem-
onstrate that rabies virus is present at the neuromuscularjunction very shortly after
inoculation of virus.
Upon entry of the virus into the peripheral nervous system, it spreads to the cen-
tral nervous system at the level of the spinal cord. This process may be achieved by
retrograde transport within axons since disruption of axons or blockade of axo-
plasmic flow prevents centripetal spread of virus [30,31]. Rabies virus has been ob-
served in sensory dorsal root ganglia 60 hours after injection of virus into the foot
pad [28]. It has also been detected in motor neurons in the ventral horn ofthe spinal
cord at 20 hours post-inoculation and before involvement of dorsal root ganglia,
providing further evidence for the primary uptake of virus at motor nerve endings
[27]. After virus reaches the spinal cord, its ascent to the brain and spread
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disseminated throughout the central nervous system by direct transfer of virus from
neuron to neuron at synapses. Virus particles have been observed by electron
microscopy budding from the postsynaptic and adjacent membranes of dendrites
and, to a lesser extent, from the plasma membrane of the perikaryon [26]. Budding
particles or particles free in the intracellular space are taken up by adjacent
presynaptic axon terminals by a process of endocytosis (Fig. 1). Although the virus
has a widespread distribution throughout the nervous system, early infection is
highly selective for certain neuronal populations [32]. For example, there is exten-
sive localization of virus in rhinencephalic structures, including hippocampus and
septal nuclei, with relative sparing ofthe neocortex. In the cerebellum, Purkinje cells
are infected, while neurons in the adjacent molecular and granular layers are not. In
rat brain, the binding of quinuclidinyl benzylate, an antagonist of the muscarinic
AChR, is markedly decreased with the onset of symptoms [33]. After central ner-
vous system infection, virus spreads centrifugally through nerves and infects the
neurons of a number of parenchymal organs [34]. In the salivary glands, virus
replicates in the acinar cells and buds from the apical surfaces of cells into the duct
system [35], thereby gaining access to the exterior in saliva.
FIG. 1. Rabies virus replication and
transfer in the molecular layer of the
cerebellum of the mouse. Numerous
rod-shaped virus particles are present
within the apical dendrite (DEN) of a
Purkinje cell. Dendrites, containing
~~~ 4 ~~~~ribosomes and Nissl substance, are
capable of synthesizing viral proteins
t ~~~~~~~~~~~~~~and supporting replication. The par-
ticles are enclosed within membranous
cisternae. Between the membranes in
the cytoplasm are masses of granular
matrix (M) material composed of viral
nucleocapsid. Processes of glial cells
(G), unmyelinated axons (AX), and
axon terminals (T) occur adjacent to
the dendrite. Some virus particles (ar-
rows) are present in the extracellular
space surrounding the cellular ele-
ments. A virus particle (*) lies within
an invagination of the surface of a
nerve terminal identified by its content
of small synaptic vesicles. Such an im-
age may represent a stage in the incor-
poration of a particle into the termi-
, nal by a process of endocytosis.
x 44,000.
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The early discrete localization of rabies virus at the neuromuscular junction [27]
suggests that some component of this region could function as a rabies virus recep-
tor. Studies undertaken recently to identify the nature of the receptor indicate the
receptor may be the acetylcholine receptor (AChR) [36]. The AChR [37] is an in-
tegral transmembrane protein which transduces a chemical signal (acetylcholine)
released by the presynaptic nerve terminal into an electrical event consisting of a
local depolarization of the postsynaptic membrane on which the receptor is located.
It consists of four subunits which interact to form a monomer with a molecular
weight of about 250,000 and dimensions of about 90 x 100 A (Fig. 2). At the
neuromuscular junction, the AChR is packed in high density on thejunctional folds
of the muscle fiber membrane.
In order to determine the receptor sites for rabies virus binding in the peripheral
nervous system, mouse diaphragms with attached phrenic nerves were immersed in a
suspension of rabies virus and stained with fluorescein-conjugated antibody to
rabies virus. Virus antigen was localized at neuromuscular junctions after 30
minutes of exposure to virus and within peripheral nerves after four hours. Rabies
virus binding and replication were also studied in cultured chick myotubes. Cultured
myotubes (immature skeletal muscle cells) contain AChR within their membranes in
both a diffuse low-density and a clustered high-density distribution [38]. When
cultured myotubes were exposed to rabies virus, antigen was distributed in patches
on the cell surface in a pattern similar to that observed following staining with
rhodamine-labeled a-bungarotoxin. The latter is a polypeptide isolated from elapid
snake venoms which binds specifically and nearly irreversibly to the nicotinic AChR
of the fish electric organ and skeletal muscle [39]. Electron microscopy of infected
myotubes showed association of rabies virus with specialized surface patches
previously shown to contain a high density of AChR [40]. Finally, pre-treatment of
myotubes with a-bungarotoxin and another ligand for the AChR, d-tubocurarine,
dramatically reduced the number of myotubes that became infected. Both of these
ligands bind to the 40,000 dalton a-subunit which contains the acetylcholine bindng
site of the AChR.
The results described above indicate that there are specific high-affinity host cell
receptor sites for rabies virus at the neuromuscular junction and on myotubes and
suggest that the receptor may be the AChR or a molecule very closely associated
with it. Other molecules present along with AChR at the neuromuscular junction in-
clude acetylcholinesterase, laminin, fibronectin, and collagen type IV [41]. These
proteins could act as virus receptor sites at the neuromuscular junction or on other
cells, although the blocking effect of the cholinergic ligands becomes more difficult
FIG. 2. Purified acetylcholine receptors from the electric
organ of Torpedo californica negatively stained with 2 per-
cent uranyl acetate. The receptor monomers appear as ro-
-'Em settes about 90 A in diameter. Each rosette possesses a cen-
tral pit 15-20 A in diameter. x 270,000.
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to explain. However, it is conceivable that these inhibitors may interfere with one of
a series of events taking place during binding and internalization of the virus.
If the AChR represents the rabies virus receptor, certain aspects of the
pathogenesis of rabies may be more readily explained. The highest density ofAChR
occurs at the tips of the junctional folds of the neuromuscular junction (about
30,000 a-bungarotoxin sites/itm2, [42]). Thus, binding ofvirus to the AChR may ef-
fectively enhance the probability of virus gaining access to the central nervous
system through motor nerve terminals. Similarly, binding to AChR at central
synapses may be responsible for the transfer and spread of virus from neuron to
neuron by concentrating virus at postsynaptic sites in proximity to presynaptic axon
terminals. Identification ofavirus receptor should also have practical significance in
providing a basis for preventing infection by blocking the attachment step. In the
case of a disease such as rabies, this could be particularly useful because host defense
mechanisms fail to prevent disease. Delay of infection, however, could increase the
effectiveness of the normal immune response or treatment by active or passive im-
munization. Finally, there are a number of chronic neurologic diseases such as
myasthenia gravis, multiple sclerosis, parkinsonism, chronic focal epilepsy,
subacute sclerosing panencephalitis, and Alzheimer's disease for which some
evidence of viral etiology exists [43]. One explanation for these diseases is that viral
binding to a cellular constituent acting as a receptor alters the receptor in some way
so that an autoimmune response is directed against it [20]. Identification of the
specific neuronal constituents to which neurotropic viruses bind will allow an
analysis of the potential effects of these interactions on functional or antigenic
alterations of receptors.
ACKNOWLEDGEMENTS
We would like to thank Helen Coxe for typing the manuscript.
Purified acetylcholine receptor was provided by Edward Hawrot.
REFERENCES
1. Crick J: Rabies. In Virus Diseases ofFood Animals: A World Geography ofEpidemiology and Con-
trol. Vol 2. Disease Monographs. Edited by EP Gibbs. London, Academic Press, 1982, pp 469-516
2. Johnson RT: Viral Infections of the Nervous System. New York, Raven Press, 1982, 433 pp
3. Dimmock NJ: Initial stages in infection with animal viruses. J Gen Virol 59:1-22, 1982
4. Rifkin DB, Compans RW: Identification of the spike proteins of a Rous sarcoma virus. Virology
46:485-489, 1971
5. Scheele CM, Hanafusa H: Proteins of helper-dependent RSV. Virology 45:401-410, 1971
6. Scheid A: Subviral components of myxo- and paramyxo-viruses which recognize receptors. In Virus
Receptors. Part 2. Animal Viruses. Edited by K Lonberg-Holm, L Philipson. London, Chapman and
Hall, 1981, pp 47-62
7. Weiss RA: Retrovirus receptors and their genetics. In Virus Receptors. Part 2. Animal Viruses.
Edited by K Lonberg-Holm, L Philipson. London, Chapman and Hall, 1981, pp 185-202
8. Wilson IA, Skehel JJ, Wiley DC: Structure of the haemagglutinin membrane glycoprotein of in-
fluenza virus at 3A resolution. Nature 289:366-373, 1981
9. Holmes KV: The biology and biochemistry of cellular receptors for enveloped viruses. In Virus
Receptors. Part 2. Animal Viruses. Edited by K Lonberg-Holm, L Philipson. London, Chapman and
Hall, 1981, pp 85-115
10. Lonberg-Holm K, Philipson L (ed): Virus Receptors. Part 2. Animal Viruses. London, Chapman
and Hall, 1981, 217 pp
11. Crowell RL, Landau BJ: Receptors as determinants ofcellular tropism in picornavirus infections. In
Receptors and Human Diseases. Edited by AG Bearn, PW Choppin. New York, Josiah Macy, Jr
Foundation, 1979, pp 1-33RABIES VIRUS RECEPTOR 321
12. Lonberg-Holm K: Attachment ofanimal viruses to cells: an introduction. In Virus Receptors. Part 2.
Animal Viruses. Edited by K Lonberg-Holm, L Philipson. London, Chapman and Hall, 1981, pp
1-20
13. Zajac I, Crowell RL: Location and regeneration of enterovirus receptors of He La cells. J Bact
89:1097-1100, 1965
14. Moldow CF, Volderding P, McGrath M, et al: Avian tumor virus interactions with chicken fibroblast
membranes: Partial characterization of initial attachment site activity. J Gen Virol 37:385-398, 1977
15. Smith AL, Tignor GH: Host cell receptors for two strains ofSindbis virus. Arch Virol 66:11-26, 1980
16. Burness ATH: Glycophorin and sialylated components as receptors for viruses. In Virus Receptors.
Part 2. Animal Viruses. Edited by K Lonberg-Holm, L Philipson. London, Chapman and Hall,
1981, pp 63-84
17. Jondal M, Klein G, Oldstone MBA, et al: Surface markers on human B and T lymphocytes. Scand J
Immunol 5:401-410, 1976
18. Helenius A, Morein B, Fries E, et al: Human (HLA-A and HLA-B) and murine (H-2K and H-2D)
histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci
USA 75:3846-3850, 1978
19. Oldstone MBA, Tishon A, Dutko FJ, et al: Does the major histocompatibility complex serve as a
specific receptor for Semliki Forest virus? J Virol 34:256-265, 1980
20. Tignor GH, Smith AL, Shope RE: Utilization of host proteins as virus receptors. In Concepts in
Viral Pathogenesis. Edited by AL Notkins, MBA Oldstone. New York, Springer Verlag, in press
21. Johnson RT: Selective vulnerability of neural cells to viral infections. Brain 103:447-472, 1980
22. Helenius A, Marsh M, White J: The entry of viruses into animal cells. Trends Biochem Sci
5:104-106, 1980
23. Dietzschold B, Wunner WH, Wiktor TJ, et al: Characterization of an antigenic determinant of the
glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80:70-74,
1983
24. Murphy FA: Rabies pathogenesis. Brief review. Arch Virol 54:279-297, 1977
25. Murphy FA, Bauer SP: Early street rabies virus infection in striated muscle and later progression to
the central nervous system. Intervirol 3:256-268, 1974
26. Charlton KM, Casey GA: Experimental rabies in skunks. Immunofluoresence light and electron
microscopic studies. Lab Invest 41:36-44, 1979
27. Watson HD, Tignor GH, Smith AL: Entry of rabies virus into the peripheral nerves of mice. J Gen
Virol 56:371-382, 1981
28. Murphy FA, Bauer SP, Harrison AK, et al: Comparative pathogenesis of rabies and rabies-like
viruses. Viral infection and transit from inoculation site to the central nervous system. Lab Invest
28:361-376, 1973
29. Harrison AK, Murphy FA: Lyssavirus infection of muscle spindles and motor end plates in striated
muscle of hamsters. Arch Virol 57:167-175, 1978
30. Bijlenga G, Heaney T: Post-exposure local treatment of mice infected with rabies with two axonal
flow inhibitors, colchicine and vinblastine. J Gen Virol 39:381-385, 1978
31. Tsiang H: Evidence for an intraaxonal transport of fixed and street rabies virus. J Neuropath Exp
Neurol 38:286-296, 1979
32. Johnson RT: Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluores-
cent antibody staining. J Neuropath Exp Neurol 24:662-674, 1965
33. Tsiang H: Neuronal function impairment in rabies-infected rat brain. J Gen Virol 61:277-281, 1982
34. Fischman HR, Schaffer M: Pathogenesis ofexperimental rabies as revealed by immunofluorescence.
Ann NY Acad Sci 177:78-97, 1971
35. Dierks RE, Murphy FA, Harrison AK: Extraneural rabies virus infection. Virus development in fox
salivary gland. Am J Path 54:251-274, 1969
36. Lentz TL, Burrage TG, Smith AL, et al: Is the acetylcholine receptor a rabies virus receptor? Science
215:182-184, 1982
37. Conti-Tronconi BM, Raferty MA: The nicotinic cholinergic receptor: Correlation ofmolecular struc-
ture with functional properties. Ann Rev Biochem 51:491-530, 1982
38. Fambrough DM: Control ofacetylcholine receptors in skeletal muscle. Physiol Rev 59:165-227, 1979
39. Lee CY: Chemistry and pharmacology of polypeptide toxins in snake venoms. Ann Rev Pharm
12:265-286, 1972
40. Burrage TG, Lentz TL: Ultrastructural characterization of surface specializations containing high-
density acetylcholine receptors on embryonic chick myotubes in vivo and in vitro. Dev Biol
85:267-286, 1981322 LENTZ ET AL.
41. Sanes JR: Laminin, fibronectin, and collagen in synaptic and extrasynaptic portions of muscle fiber
basement membrane. J Cell Biol 93:442-451, 1982
42. Fertuck HC, Salpeter MM: Quantitation ofjunctional and extrajunctional acetylcholine receptors by
electron microscope autoradiography after '25l-a-bungarotoxin binding at mouse neuromuscular
junctions. J Cell Biol 69:144-158, 1976
43. Johnson RT, ter Meulen V: Slow infections of the nervous system. Adv Int Med 23:353-383, 1978